Brief: Ose Immunotherapeutics Announces Manufacturing Agreement With Cenexi

Ose Immunotherapeutics SA

30/06/2021 06:34

June 30 (Reuters) - Ose Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS ANNOUNCES MANUFACTURING AGREEMENT
WITH
CENEXI FOR CLINICAL BATCHES OF COVEPIT, OSE’S MULTI-TARGET
SECOND-GENERATION COVID-19 VACCINE
    * UNDER THIS AGREEMENT, CENEXI WILL MANUFACTURE AND PROCESS
PEPTIDES, PRODUCE STERILE EMULSION AND PACKAGE CLINICAL BATCHES
OF COVEPIT BEING USED IN ONGOING PHASE 1 CLINICAL TRIAL AND
POTENTIALLY FOR FURTHER CLINICAL PHASES, SUBJECT TO POSITIVE
RESULTS OF PHASE 1

Source text for Eikon:  ID:nBw6bHqGJa 
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))